Trial Profile
Prognostic Factors and Risk-Adapted Therapy in Patients With Early Stage Chronic Lymphocytic Leukemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Fludarabine (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 10 Aug 2016 Status changed from active, no longer recruiting to completed.
- 08 Dec 2007 Results reported at ASH 2007
- 05 Sep 2006 New trial record.